Back to search

Italy· 050222013

YSELTY*28 cpr rivestite 100 mg

A linzagolix product containing linzagolix, registered in Italy by THERAMEX IRELAND LIMITED, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC H01CC04

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedYSELTY*28 cpr rivestite 100 mgATCH01CC04REGISTER NO.050222013PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Linzagolix is registered in 12 of 19 countries.

Countries holding a registration under ATC H01CC04 (linzagolix), each read from that country’s own register.

  • This record: Italy
  • 8 of them publish a price we can compare per daily dose

Linzagolix · ATC H01CC04

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of linzagolix costs, country by country.

Normalised to the WHO defined daily dose (0.13 g), so markets compare like for like.

  • Italy: $6.85 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Linzagolix · price per daily dose (0.13 g)

USD · FX 28 Sept 2026

  • IT Italy$6.85
  • ES Spain$5.81
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Linzagolix
Manufacturer
THERAMEX IRELAND LIMITED
Country
Italy (IT)
ATC code
H01CC04
ATC class
Linzagolix
Defined daily dose
0.13 g, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    050222013
    YSELTY*28 cpr rivestite 100 mg
    EUR 172.79

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Linzagolix in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All linzagolix products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Yselty
  • Liechtenstein · Yselty
  • Norway · Yselty

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2e3452d4-27b4-410a-a738-0d007200e134
GET /v1/drugs/2e3452d4-27b4-410a-a738-0d007200e134?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 172.79,
  "source": "aifa",
  "currency": "EUR",
  "strength": "LINZAGOLIX 100MG 28 UNITA' USO ORALE",
  "substance": "Linzagolix",
  "equivalence_group": "NEM",
  "transparency_flag": null
}

See everything about linzagolix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.